Arbutus Biopharma Corp. (ABUS)
4.46
-0.02
(-0.45%)
USD |
NASDAQ |
Apr 06, 16:00
4.475
+0.02
(+0.34%)
After-Hours: 20:00
Arbutus Biopharma Profit Margin (Quarterly) : -357.4% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -121.8% |
| Merck & Co., Inc. | 18.15% |
| Pfizer Inc. | -9.34% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.51% |
| Return on Assets | -30.77% |
| Return on Invested Capital | -38.16% |
| Gross Profit Margin (Quarterly) | 98.95% |
| Operating Margin (Quarterly) | -727.3% |
| Return on Net Operating Assets | -1.42K% |